选择尺寸
关于此项目
产品名称
地高辛, Pharmaceutical Secondary Standard; Certified Reference Material
InChI key
LTMHDMANZUZIPE-PUGKRICDSA-N
InChI
1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1
SMILES string
C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4
grade
certified reference material
pharmaceutical secondary standard
agency
traceable to Ph. Eur. D1900000
traceable to USP 1200000
API family
digoxin
CofA
current certificate can be downloaded
packaging
pkg of 300 mg
technique(s)
HPLC: suitable
gas chromatography (GC): suitable
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-30°C
Quality Level
Gene Information
human ... ATP1A1(476), ATP1A2(477), ATP1A3(478), ATP1A4(480), ATP1B1(481), ATP1B2(482), ATP1B3(483), FXYD2(486)
正在寻找类似产品? 访问 产品对比指南
Analysis Note
Other Notes
Application
Biochem/physiol Actions
General description
地高辛是一种毛地黄糖苷(digitalis glycoside),广泛用于治疗充血性心力衰竭(CHF)。它具有正性肌力作用、抗心律失常及血管收缩作用。据报道地高辛和其他强心苷可能在预防和/或治疗癌症等增生性疾病中发挥重要作用。
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 2 Oral - Acute Tox. 3 Inhalation - STOT RE 2
存储类别
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
wgk
WGK 3
法规信息
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持
